The Lancet HIV in conversation with
by The Lancet Group
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Episodes
-
Implementation of long-acting injectable cabotegravir for PrEP in Brazil with Beatriz Grinsztejn
Daily oral PrEP is highly effective, but taking a pill consistently can be challenging. Could long-acting injectable cabotegravir help close gaps in HIV prevention? What would it take to make it available through Brazil’s public health system? In this episode, the authors discuss the ImPrEP CAB...
-
Joanne Langley and Innocent Valea on Ebola vaccine in people living with HIV
Ebola outbreaks occur in areas where many people are living with HIV; however, there is very little evidence on how people with HIV respond to Ebola vaccines. In this edition of the podcast, we talk to authors of a study assessing the safety and immunogenicity of an Ebola vaccine in people with...
-
Janet Turan and Zachary Kwena on home-based couples testing and counselling for HIV
HIV remains underdiagnosed among men in many settings, contributing to ongoing transmission. When women seek care during pregnancy, there is an opportunity to reach out to their partners. Home-based couples testing and counselling can help to identify HIV and discuss other health issues. In this...
-
Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV
Living longer with HIV is one of medicine's greatest success stories, but longevity brings new challenges. By 2040, more than half of all people living with HIV are expected to be over the age of 50, and their health pathways during ageing are very heterogeneous. What does that mean for patients,...
-
Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy
Some people on HIV treatment have a viral load that won't fully suppress. In this episode, we speak with Annemarie Wensing (University Medical Center Utrecht in The Netherlands and Witwatersrand University in South Africa), Aryen Stam (University Medical Center Utrecht) and Tomasso Clemente…
more -
David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV
Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance use—new research quantifies this burden, and we discuss the findings with the authors and explore drivers and solutions.…
more -
Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial
Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV. Esteban Martinez from the Hospital Clinic and University…
more -
Colette Smith on the Positive Voices UK survey recording health needs of people living with HIV
People living with HIV often have many health needs beyond their antiretroviral medication. Editor in Chief Peter Hayward talks to Colette Smith of the Institute for Global Health at University College London about results of the Positive Voices survey identifying unmet health needs for people…
more -
Eran Shorer on Parkinsonism in people with virally suppressed HIV
Ageing with HIV brings new challenges. Even with effective ART, people ageing with HIV face increased risk of parkinsonism. Eran F Shorer from the Icahn School of Medicine at Mount Sinai joins us to explore the latest research on brain changes, motor slowing, and the need for better diagnosis and...
-
Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa
Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are...
-
Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV
Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances. Click here to read…
more -
Deborah Persaud on the possibility of HIV remission in neonates
In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far. Read the full article:...
-
Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis
Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving...
-
Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV
Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says…
more -
Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a...
-
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Read the full article:...
-
Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of…
more -
Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality
Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study...
-
Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression. Read the article:...
-
Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women
Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women. Read the full article:...
-
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies. Read the full article:...
-
Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)
Please note: this podcast is entirely in Spanish Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el...
-
Florence Riako Anam and Bruce Richman on U=U
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat. Read the full Article:...
-
Peter Hayward on 10 years of The Lancet HIV
Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV. Read this month´s anniversary editorial here:...
-
Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa
Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission. Read the full article:...
-
José M. Zuniga on the future of urban HIV responses Commission
Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...
-
Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)
Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España…
more -
Serge Eholie on treatments for HIV-2
Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo. Read the full article:...
-
Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana
Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95...
-
Adam Trickey on trends in causes of death among people with HIV in Europe and North America
Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America. Read the full article:...
-
Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK
Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective...
-
Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women
Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in...
-
Sophia Rein on HIV treatment with INSTIs and cardiovascular events
Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV. Continue this conversation on social! Follow us today at......
-
Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist
Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies. Read the full article:...
-
Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence
We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal. Read the full article:...
-
Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations
Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV…
more -
Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)
Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes…
more -
Denton Callander on the effects of treatment as prevention
Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia. Read the full article:...
-
Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women
Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA. Read the full article:...
-
Yasmin Mohamed on early infant diagnosis of HIV
Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea. Read the full article: The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New...
-
Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV
Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV...
-
Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting...
-
Helen Ayles and Musonda Simwinge on the PopART trial
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV. Read the PopART trial papers: Viral suppression and self-reported ART adherence after 3 years...
-
Carol Strong and Stephane Ku on HIV and chemsex
Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex. Read the full Review: HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have...
-
Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV
Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda. Read the full article: A mid-level…
more -
Amir Mohareb on PrEP and hepatitis B
Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. Read the full article: Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B Continue this conversation on social! Follow us…
more -
Kenneth Ngure on PrEP in Kenya
Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing. Read the full article: Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya…
more -
Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians
Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine. Continue this conversation on...
-
Angela Colbers and Hylke Waalewijn on treatment for children with HIV
Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. Read the full article: Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety...
-
Nabila El-Bassel on intimate partner violence and HIV
Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal...
About this show
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Hosted by
The Lancet Group